4-82-725
| 规格 | 目录价格 | 上海 | 安徽 | 武汉 | 成都 | 北方 | 深圳 | 会员价格 | 数量 |
|---|---|---|---|---|---|---|---|---|---|
| g | ￥ üųĢƖƖ | 9 | > | -- | -- | ￥ üųĢƖƖ | - + | ||
| 5g | ￥ ŠǷĢƖƖ | 7 | > | -- | -- | 2 | ￥ ŠǷĢƖƖ | - + | |
| g | ￥ ŒƖĢƖƖ | 6 | 9 | 4 | -- | -- | 2 | ￥ ŒƖĢƖƖ | - + |
| 25g | ￥ ĭĭĢƖƖ | 6 | 4 | -- | -- | -- | ￥ ĭĭĢƖƖ | - + | |
| g | ￥ ŠĭųĢƖƖ | 4 | -- | -- | -- | 2 | ￥ ŠĭųĢƖƖ | - + | |
| 5g | ￥ ǷňĭǦĢƖƖ | -- | -- | -- | -- | -- | ￥ ǷňĭǦĢƖƖ | - + | |
| kg | ￥ üĭƖųĢƖƖ | -- | -- | -- | -- | -- | -- | ￥ üĭƖųĢƖƖ | - + |
| 大货 | 请询价 | -- | -- | -- | -- | -- | -- | -- | - + |
9.2
[]. Mark Johnson, et al. Structure-activity relationship study of N?-(2-(4-(H-Indol-5-yl)piperazin--yl)ethyl)-N?-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: development of highly selective D dopamine receptor agonists along with a highly potent D2/D agonist and their pharmacological characterization. J Med Chem. 22 Jun 28;55(2):5826-4.
H227-H5-H9-H5
P2-P26-P264-P27-P28-P2+P52-P4+P4-P62+P64-P7+P78-P4-P45-P5
GHS7
74962 现货
￥ üųĢƖƖ -5g
272 现货
￥ ŠŠĢƖƖ -25mg
675 现货
￥ üųĢƖƖ -g
29445 现货
￥ üųĢƖƖ -g
5697 现货
￥ ŠƩĢƖƖ -25mg
245 现货
￥ ĭŠĢƖƖ -mg
2225 现货
￥ ŠüĢƖƖ -25mg
22558 现货
￥ ųĭĢƖƖ -g
24546 货期咨询
24888 货期咨询
￥ ǷƩƖƖĢƖƖ -mg
沪ICP备79645号
